CSPC Pharmaceutical Group Limited. - ADR
CSPCY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.17B
Close$
$1.87
56.3% downside
Current Fair Value
56.3% downsideOvervalued by 56.3% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $12.17 Billion |
|---|---|
| Enterprise Value | $3.46 Billion |
| Annual dividend | $0.15 |
| Dividend yield | 3.91% |
| Earnings per Share | $1.32 |
| Beta | 0.75 |
| Outstanding Shares | 2,850,291,500 |
Return
| Return on Equity | 25.03% |
|---|---|
| Return on Assets | 16.81% |
| Return on Invested Capital | 31.94% |
Valuation & Multiples
| P/E Ratio | 11.05 |
|---|---|
| PEG | 0.68 |
| Price to Sales | 0.25 |
| Price to Book Ratio | 0.33 |
| Enterprise Value to Revenue | 0.07 |
| Enterprise Value to EBIT | 0.26 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Last Earnings Call
Report Date
May 27, 2026
EPS
$0.06
ReportedRevenue
$1.60 B
Est. $7.58 BInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CSPC Pharmaceutical Group Limited.
18,626 employees
CEO: Lei Cai
CSPC Pharmaceutical Group Limited, primarily an investment holding entity, is dedicated to the development, production, and distribution of pharmaceutical goods. Its operations span the globe, with a significant presence in the People's ...